Queen’s Speech 2021: UK Government confirms plans to establish Advanced Research and Invention Agency
The Queen’s Speech was held yesterday, 11 May 2021, announcing the UK Government’s plans for the year ahead We were pleased to see that the Government is planning ‘the fastest ever… read more…
EPO 2020 filing trends report confirms strong growth in healthcare technologies
A recent report published by the European Patent Office (EPO) shows that despite the disruption caused by the COVID pandemic, the number of EP applications filed in 2020 remained stable overall,… read more…
Decarbonising the automotive sector: Luxury car manufacturers investing in electromobility
It is clear for anyone watching the energy space, that hydrogen and electric vehicles (EVs) are two areas of significant investment and innovation in recent years, the two forming part of… read more…
Mathys & Squire trainees excel in latest exams
In what has been a particularly difficult year for all students across the world, with much uncertainty and logistical changes, we are delighted to announce a record number of exam success for… read more…
Level up your IP strategy: the patentability of video games in the UK and Europe
In this article for The Patent Lawyer, Andrew White and Conor McGuinness develop key insights into patenting video games with exploration of unsuccessful and successful case examples Image… read more…
No ‘Get Out of Jail Free’ card for Hasbro
The General Court (‘GC’) has refused an appeal by Hasbro Inc (‘Hasbro’) regarding the decision to partially invalidate a registration of its MONOPOLY mark on the ground of bad… read more…
Application of Article 53(a) EPC – Considering the morality of pharmaceutical inventions
The European Patent Office (EPO)’s Technical Board of Appeal 3301, in recent decision T 1553/15, has provided guidance on the patentability exclusion under Article 53(a) EPC, which prescribes that… read more…
Mathys & Squire Consulting launched to formalise successful commercial IP services offering
The launch of Mathys & Squire Consulting follows the exciting acquisition of leading IP consulting firm Coller IP in 2017, when Mathys & Squire sought to develop its IP strategy and… read more…
Protecting non-therapeutic methods at the EPO
Like many patent offices, the EPO does not allow applicants to claim methods for treatment of the human or animal body by surgery or therapy (Article 53(c) EPC) Such exclusions are historically… read more…
